The U.S. FDA recently approved the Itovebi-based regimen as a first-line treatment for people with HR+, Her2-negative breast ...
With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.
The quality of digital PCR data can only be as high as the assays used to obtain it. High-quality assays ensure that the ...
In this episode of Targeted Talks, Seth Wander, MD, PhD, discusses the clinical importance of ESR1 mutations in HR-positive ...
BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) to report its financial ...
Summer V Allen; Lise Solberg Nes; Mary L Marnach; Kristen Polga; Sarah M Jenkins; Julia A Files; Ivana T Croghan; Karthik Ghosh; Sandhya Pruthi The current study sought to investigate the impact ...
Future Oncol. 2015;11(7):1023-1026. Tumor-negative breast cancers misclassified as HER2 negative by IHC (0 or 1+) could therefore be reclassified by FISH, with a remarkable impact on medical ...
And STDs can be cured or treated. Planned Parenthood health centers offer STD testing and treatment, and our caring and non-judgmental staff can provide information and resources to help you prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback